Innovation in Development and Qualification of Alternative Testing Methodologies for Reproductive Toxicology (U01)

The summary for the Innovation in Development and Qualification of Alternative Testing Methodologies for Reproductive Toxicology (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.

Innovation in Development and Qualification of Alternative Testing Methodologies for Reproductive Toxicology (U01): As part of Food and Drug Administration's Advancing Regulatory Science initiative the Office of Critical Path Programs (OCPP) supports innovation to improve the development and evaluation of new safe and effective medical products for diagnosing, treating, and preventing conditions and diseases. OCPP is working to harness new science and new technologies to further this goal.This Funding Opportunity Announcement (FOA) will provide resources for research into the development and qualification of alternative methodologies in the area of reproductive toxicology, which have the potential to be more predictive than the currently required testing, and which will reduce, refine, or replace animal testing.Applications should address the Critical Path Initiative's mission to facilitate the development of new safe and effective products for diagnosing, treating, and preventing disease.

Federal Grant Title:	Innovation in Development and Qualification of Alternative Testing Methodologies for Reproductive Toxicology (U01)
Federal Agency Name:	Food and Drug Administration
Grant Categories:	Health Science and Technology
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-FD-11-017
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.103
CFDA Descriptions:	Food and Drug Administration_Research
Current Application Deadline:	Jun 16, 2011
Original Application Deadline:	Jun 16, 2011
Posted Date:	May 05, 2011
Creation Date:	May 05, 2011
Archive Date:	Jul 16, 2011
Total Program Funding:	$1,000,000
Maximum Federal Grant Award:	$350,000
Minimum Federal Grant Award:	$250,000
Expected Number of Awards:	20
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education
Additional Information on Eligibility: PLEASE Note: The entities eligible to enter into partnerships with FDA are governed by Section 566 of the FD&C Act [21 U.S.C. 360bbb-5]. An eligible organization that wishes to enter into a collaborative agreement must provide an assurance that the entity will not accept funding for a Crtical Path Public-Private Partnership Project from any organization that manufactures or distributes products regulated by the Food and Drug Administration (FDA)unless the entity provides assurances in its agreement with FDA that the results of the Critical Path Public-Private Partnership Project will not be influenced by any source of funding.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: Gladys M. Bohler Grants Management Officer/Specialist Phone 301-827-7175

FDA office e-mail [[email protected]]
Similar Government Grants: • Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, a...; • Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical...; • Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biologic...; • Cooperative Agreement to Support the World Trade Organization's (WTO) Standards and Trade ...; • Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) ...; • Support for Small Scientific Conference Grant Program; • Cooperative Agreement to Support the World Health Organization (WHO) International Program...; • Clinical Studies of Safety and Effectiveness of Orphan Products
More Grants from the Food and Drug Administration: • Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, a...; • Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical...; • Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biologic...